相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
E. El Rassy et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
PD-1/PD-L1 blockade rescue exhausted CD8+T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway
Rui Zhao et al.
CELL PROLIFERATION (2019)
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells
Sema Kurtulus et al.
IMMUNITY (2019)
Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui et al.
IMMUNITY (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
CRISPR-Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV-host factor interactions
Judd F. Hultquist et al.
NATURE PROTOCOLS (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy
Kenneth M. Felsenstein et al.
NATURE REVIEWS UROLOGY (2018)
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis
Vincenzo Di Nunno et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma
Tom Powles et al.
NATURE REVIEWS UROLOGY (2018)
Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
David T. Miyamoto et al.
LANCET ONCOLOGY (2018)
Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions
Abhishek Tripathi et al.
CURRENT UROLOGY REPORTS (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune checkpoint inhibitors for urothelial carcinoma
Hyung Suk Kim et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2018)
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
Shu Su et al.
ONCOIMMUNOLOGY (2017)
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Guoying Zhou et al.
GASTROENTEROLOGY (2017)
Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
Joost Dejaegher et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Proliferation of PD-1+CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
Alice O. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
Higher PD-1 expression concurrent with exhausted CD8+T cells in patients with de novo acute myeloid leukemia
Jiaxiong Tan et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Immunotherapy: a new treatment paradigm in bladder cancer
Nicole N. Davarpanah et al.
CURRENT OPINION IN ONCOLOGY (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
Aude G. Chapuis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma
Wei Zhang et al.
CANCER MEDICINE (2016)
Tumor-infiltrating Tim-3(+) T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk
Jing Li et al.
ONCOIMMUNOLOGY (2016)
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
Shu Su et al.
SCIENTIFIC REPORTS (2016)
Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade
Elizabeth Buchbinder et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Drug-Associated Dermatomyositis Following Ipilimumab Therapy A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade
Shirwa Sheik Ali et al.
JAMA DERMATOLOGY (2015)
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Danielle M. Lussier et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
分享论文
